| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
|
Rubbert-Roth, Andrea
|
|
|
3 |
7 |
p. e470-e472
|
artikel
|
| 2 |
A personal and diagnostic odyssey
|
Morgan, Jules
|
|
|
3 |
7 |
p. e480
|
artikel
|
| 3 |
Avoiding diagnostic pitfalls in children with musculoskeletal symptoms
|
van Suijlekom-Smit, Lisette W A
|
|
|
3 |
7 |
p. e467-e468
|
artikel
|
| 4 |
Correction to Lancet Rheumatol 2021; 3: e438–46
|
|
|
|
3 |
7 |
p. e478
|
artikel
|
| 5 |
COVID-19 in patients with rheumatic disease: finally, a denominator
|
Wallace, Daniel J
|
|
|
3 |
7 |
p. e462-e463
|
artikel
|
| 6 |
Flare of rheumatoid arthritis after COVID-19 vaccination
|
Terracina, Katherine A
|
|
|
3 |
7 |
p. e469-e470
|
artikel
|
| 7 |
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study
|
Civino, Adele
|
|
|
3 |
7 |
p. e507-e516
|
artikel
|
| 8 |
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
|
Drake, Thomas M
|
|
|
3 |
7 |
p. e498-e506
|
artikel
|
| 9 |
Non-steroidal anti-inflammatory drug use in COVID-19
|
Kragholm, Kristian
|
|
|
3 |
7 |
p. e465-e466
|
artikel
|
| 10 |
Pain in arthritis: a universal reality
|
The Lancet Rheumatology,
|
|
|
3 |
7 |
p. e461
|
artikel
|
| 11 |
Polyarthritis and swollen hands and feet in an 80-year-old woman
|
Mir, Tajamul H
|
|
|
3 |
7 |
p. e532
|
artikel
|
| 12 |
Quantification of 68Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease
|
Broens, Bo
|
|
|
3 |
7 |
p. e475
|
artikel
|
| 13 |
Quantification of 68Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease – Authors' reply
|
Distler, Jörg HW
|
|
|
3 |
7 |
p. e475-e477
|
artikel
|
| 14 |
Research in Brief
|
Thorley, Jennifer
|
|
|
3 |
7 |
p. e479
|
artikel
|
| 15 |
Rituximab for the treatment of systemic sclerosis: urgent need for an international randomised controlled trial
|
Hughes, Michael
|
|
|
3 |
7 |
p. e463-e465
|
artikel
|
| 16 |
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
|
Ebata, Satoshi
|
|
|
3 |
7 |
p. e489-e497
|
artikel
|
| 17 |
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
|
Saadoun, David
|
|
|
3 |
7 |
p. e481-e488
|
artikel
|
| 18 |
Targeting GM-CSF in rheumatological conditions: risk of PAP
|
Rooney, Leah
|
|
|
3 |
7 |
p. e473
|
artikel
|
| 19 |
Targeting GM-CSF in rheumatological conditions: risk of PAP – Authors' reply
|
Genovese, Mark C
|
|
|
3 |
7 |
p. e473-e474
|
artikel
|
| 20 |
The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus
|
Mok, Chi Chiu
|
|
|
3 |
7 |
p. e517-e531
|
artikel
|
Tijdschrift beschrijving